Literature DB >> 1602321

Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.

N Turjanski, A J Lees.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602321      PMCID: PMC489093          DOI: 10.1136/jnnp.55.5.413

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Potentiation of the "dopa" effect in parkinsonism by a direct GABA receptor agonist.

Authors:  K J Bergmann; J C Limongi; Y H Lowe; M R Mendoza; M D Yahr
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

2.  Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.

Authors:  J M Gaio; P Pollak; M Hommel; J Perret
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

Review 3.  A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.

Authors:  A R Crossman
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

  3 in total
  3 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 2.  Antiseizure Drugs and Movement Disorders.

Authors:  Michel Sáenz-Farret; Marina A J Tijssen; Dawn Eliashiv; Robert S Fisher; Kapil Sethi; Alfonso Fasano
Journal:  CNS Drugs       Date:  2022-07-21       Impact factor: 6.497

Review 3.  Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

Authors:  G Linazasoro; N Van Blercom; L Ugedo; J A Ruiz Ortega
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.